共 50 条
- [2] SUPPRESSIBILITY OF THYROID FUNCTION DURING TREATMENT WITH ANTITHYROID DRUGS IN GRAVES DISEASE [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (03): : 406 - +
- [3] PLASMA DOPAMINE-BETA-HYDROXYLASE ACTIVITY AND THYROID SUPPRESSIBILITY IN GRAVES-DISEASE [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (08): : 828 - 830
- [4] DISSOCIATION OF SERUM LATS CONTENT AND THYROID SUPPRESSIBILITY DURING TREATMENT OF HYPERTHYROIDISM [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (04): : 524 - +
- [5] THYROID-STIMULATING ANTIBODY (TSAB) IN GRAVES-DISEASE - ITS RELATIONSHIP TO LATS [J]. CLINICAL RESEARCH, 1977, 25 (03): : A515 - A515
- [6] LATS AND HUMAN-SPECIFIC THYROID-STIMULATOR - THEIR RELATION TO GRAVES-DISEASE [J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1975, 4 (02): : 319 - 339
- [8] LATS OR THYROID-STIMULATING IMMUNOGLOBULIN AS A PROGNOSTIC INDEX OF RELAPSE IN HYPERTHYROIDISM OF GRAVES-DISEASE [J]. ACTA ENDOCRINOLOGICA, 1976, 82 : 12 - 12